Thirty years ago, in the summer of 1989, the U.S. Patent and Trademark Office granted a patent to a retinal surgeon Gholam Peyman, MD, for a “Method for Modifying Corneal Curvature.”1
For many ODs, Lyme disease (Borrelia burgdoferi) and it’s 22+ variant cousins hit close to home.
While a hot topic of late, it is easy to forget that the concept of artificial intelligence (AI) is not new.
I don’t like to read. I never did, and, still today, I’m more of a “wait until the movie comes out” kind of guy. I’m very fortunate in that our kids take after their mother in this regard (among others).
A 39-year-old male attended the clinic seeking a second opinion for a right-eye problem for which he had been treated elsewhere.
I practice in a multidisciplinary setting where professional collaborative engagement of all medical specialties is highly valued and practiced on a daily basis.
While the science of nutrition has been evolving for years, its role in patient care has long remained elusive.
A healthy corneal epithelium is fundamental to healthy vision, and several corneal epithelial diseases are associated with severe consequences to overall ocular health.1,2
Our practice has been performing epi-off corneal collagen cross-linking (CXL) since it was approved by the U.S. Food & Drug Administration (FDA) for patients with progressive keratoconus or ectasia.
A 64-year-old Caucasian male presented for a comprehensive eye exam with chief complaint of mild blur at distance and near with his progressive addition lenses as well as a peeling anti-reflective coating.
Where did you grow up?